Barrington Strategic Wealth Management Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Barrington Strategic Wealth Management Group's NVS Position: Q3 2017 in Review
Barrington Strategic Wealth Management Group increased its Novartis (NVS) stake by 0.2% in Q3 2017, buying an estimated $3.32K and bringing the position to 22,505 shares worth $1.73M. The position accounts for 0.87% of the portfolio, ranked #32.
Barrington Strategic Wealth Management Group first reported a position in NVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $2.38M in Q1 2015. 937 funds tracked by Wall St. Rank hold NVS as of Q3 2017.
- Barrington Strategic Wealth Management Group held 22,505 shares of Novartis worth $1.73M as of Q3 2017.
- Barrington Strategic Wealth Management Group bought 44 Novartis shares in Q3 2017, an estimated $3.32K.
- Novartis made up 0.87% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #32 holding.
- Barrington Strategic Wealth Management Group first reported a position in Novartis in Q2 2013 and has held it in 18 quarters since.
- Barrington Strategic Wealth Management Group's Novartis position peaked at $2.38M in Q1 2015.
- 937 funds tracked by Wall St. Rank held Novartis as of Q3 2017.
Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.